Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Jing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2423-9206; OpenAlex author ID A5120989748. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. Co-author DOI 10.1038/s41419-026-08439-0↗
  2. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy. Co-author DOI 10.3389/fimmu.2021.690056↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Chen · 1 shared paper, 2026 · strength 0.28
  2. Tao Huang · 1 shared paper, 2026 · strength 0.28
  3. Wei Cui · 1 shared paper, 2026 · strength 0.28
  4. Hezhi Fang · 1 shared paper, 2026 · strength 0.28
  5. Hangqi Liu · 1 shared paper, 2021 · strength 0.14
  6. Hui Zhang · 1 shared paper, 2021 · strength 0.14
  7. Huanwen Wu · 1 shared paper, 2021 · strength 0.14
  8. Xiaoding Liu · 1 shared paper, 2021 · strength 0.14
  9. Ruiyu Li · 1 shared paper, 2021 · strength 0.14
  10. Zhiyong Liang · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.